EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21waf1/cip1 and by inhibiting mutant p53-Reference-Cited by-同舟云学术

EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21waf1/cip1 and by inhibiting mutant p53

Published:2013-08 Issue:1 Volume:336 Page:53-60
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Seward Shelly,Semaan Assaad,Qazi Aamer M.,Gruzdyn Oksana V.,Chamala Sreedhar,Bryant Christopher C.,Kumar Sanjeev,Cameron David,Sethi Seema,Ali-Fehmi Rouba,Morris Robert,Bouwman David L.,Munkarah Adnan R.,Weaver Donald W.,Gruber Scott A.,Batchu Ramesh B.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2012

2. Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review;Seidman;Int. J. Gynecol. Cancer,2012

3. Clinical update: novel targets in gynecologic malignancies;Aghajanian;Semin. Oncol.,2004

4. Polycomb silencers control cell fate, development and cancer;Sparmann;Nat. Rev. Cancer,2006

5. The functions of E (Z)/EZH2-mediated methylation of lysine 27 in histone H3;Cao;Curr. Opin. Genet. Dev.,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bromodomain Protein BRD4-Mediated Mutant p53 Transcription Promotes TNBC Progression;International Journal of Molecular Sciences;2022-12-02

2. H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes;Cells;2022-10-26

3. Peritoneal Modulators of Endometriosis-Associated Ovarian Cancer;Frontiers in Oncology;2021-11-25

4. Overexpression of miRNA-3613-3p Enhances the Sensitivity of Triple Negative Breast Cancer to CDK4/6 Inhibitor Palbociclib;Frontiers in Oncology;2020-11-27

5. Roles of long non-coding RNAs in the hallmarks of glioma;ONCOL LETT;2020